CalcitoninHormone TherapySafety Rating 8/10
Primary research areaPostmenopausal osteoporosis
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range200 IU intranasal daily (osteoporosis); 100 IU SC/IM for hypercalcemia
AdministrationNasal spray or subcutaneous injection
Safety8/10 · FDA-approved (Miacalcin)
NCAA D1Not listed
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Calcitonin
Mechanism of action
Inhibits osteoclast-mediated bone resorption; reduces serum calcium
Safety profile
Nasal irritation, rhinitis, back pain; possible malignancy signal · Long history of use; nasal irritation; slight cancer signal led to EMA re-evaluation but still available
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Calcitonin below your target.
Related pages